Docmorris AG Revenue And Adjusted EBITDA Guidance For 2026 Increased

By Reuters News

Oct 15 (Reuters) - DocMorris AG DOCM.S:

  • DOCMORRIS ACCELERATES RX GROWTH TO 78% IN Q3; EBITDA BREAKEVEN ALREADY ACHIEVED IN Q3 AND REVENUE AND EBITDA FORECAST FOR 2026 RAISED AGAIN

  • ACHIEVES Q3 EBITDA BREAKEVEN; RAISES 2026 REVENUE AND EBITDA FORECAST

  • REVENUE AND ADJUSTED EBITDA GUIDANCE FOR 2026 INCREASED

  • REPURCHASES CHF 49.60 MILLION CONVERTIBLE BOND MATURING 2028; ISSUES NEW BOND MATURING 2031

  • ADJUSTED EBITDA OF CHF 0.6 MILLION IN Q3

  • 9M DIGITAL SERVICES REVENUE GROWS 62.0% TO CHF 41 MILLION

  • 9M EXTERNAL REVENUE UP 15.5% TO CHF 970.60 MILLION; REVENUE UP 16.4% TO CHF 926.60 MILLION

Further company coverage: DOCM.S

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.